Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 121, Issue 6, 2018, Pages 718-724

  Cavallari, Ilaria ^a   Patti, Giuseppe ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CLOPIDOGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR ANTAGONIST; RIVAROXABAN; UNCLASSIFIED DRUG; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; BLOOD CLOT LYSIS; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DUAL ANTIPLATELET THERAPY; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STENT THROMBOSIS; TREATMENT OUTCOME; TRIPLE ANTITHROMBOTIC THERAPY; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ATRIAL FIBRILLATION; DRUG THERAPY, COMBINATION; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOEMBOLISM;

EID: 85040599048     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2017.12.014     Document Type: Article

References (26)

1. Valgimigli, M., Bueno, H., Byrne, R.A., Collet, J.-P., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P., Mauri, L., Montalescot, G., Neumann, F.-J., Petricevic, M., Roffi, M., Steg, P.G., Windecker, S., Zamorano, J.L., 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 2017, 10.1093/eurheartj/ehx419 [Epub ahead of print].
2. Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., Hindricks, G., Manolis, A.S., Oldgren, J., Popescu, B.A., Schotten, U., Van Putte, B., Vardas, P., Agewall, S., Camm, J., Baron Esquivias, G., Budts, W., Carerj, S., Casselman, F., Coca, A., De Caterina, R., Deftereos, S., Dobrev, D., Ferro, J.M., Filippatos, G., Fitzsimons, D., Gorenek, B., Guenoun, M., Hohnloser, S.H., Kolh, P., Lip, G.Y.H., Manolis, A., McMurray, J., Ponikowski, P., Rosenhek, R., Ruschitzka, F., Savelieva, I., Sharma, S., Suwalski, P., Tamargo, J.L., Taylor, C.J., Van Gelder, I.C., Voors, A.A., Windecker, S., Zamorano, J.L., Zeppenfeld, K., 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37 (2016), 2893–2962.
3. Amsterdam, E.A., Wenger, N.K., Brindis, R.G., Casey, D.E., Ganiats, T.G., Holmes, D.R., Jaffe, A.S., Jneid, H., Kelly, R.F., Kontos, M.C., Levine, G.N., Liebson, P.R., Mukherjee, D., Peterson, E.D., Sabatine, M.S., Smalling, R.W., Zieman, S.J., ACC/AHA Task Force Members, Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130 (2014), 2354–2394.
4. Paikin, J.S., Wright, D.S., Crowther, M.A., Mehta, S.R., Eikelboom, J.W., Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents. Circulation 121 (2010), 2067–2070.
5. Dewilde, W.J.M., Oirbans, T., Verheugt, F.W.A., Kelder, J.C., De Smet, B.J.G.L., Herrman, J.-P., Adriaenssens, T., Vrolix, M., Heestermans, A.A.C.M., Vis, M.M., Tijsen, J.G.P., van ‘t Hof, A.W., ten Berg, J.M., WOEST study investigators. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381 (2013), 1107–1115.
6. Gibson, C.M., Mehran, R., Bode, C., Halperin, J., Verheugt, F.W., Wildgoose, P., Birmingham, M., Ianus, J., Burton, P., Eickels, M., van Korjian, S., Daaboul, Y., Lip, G.Y.H., Cohen, M., Husted, S., Peterson, E.D., Fox, K.A., Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 375 (2016), 2423–2434.
7. Cannon, C.P., Bhatt, D.L., Oldgren, J., Lip, G.Y.H., Ellis, S.G., Kimura, T., Maeng, M., Merkely, B., Zeymer, U., Gropper, S., Nordaby, M., Kleine, E., Harper, R., Manassie, J., Januzzi, J.L., Ten Berg, J.M., Steg, P.G., Hohnloser, S.H., RE-DUAL PCI Steering Committee and Investigators. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377 (2017), 1513–1524.
8. Higgins, J.P.T., Green, S., (eds.) Cochrane Handbook for Systematic Reviews of Interventions, 2005, John Wiley Sons, Chichester, UK.
9. Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J., Gavaghan, D.J., McQuay, H.J., Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996), 1–12.
10. DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
11. Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
12. Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994), 1088–1101.
13. Fiedler, K.A., Maeng, M., Mehilli, J., Schulz-Schüpke, S., Byrne, R.A., Sibbing, D., Hoppmann, P., Schneider, S., Fusaro, M., Ott, I., Kristensen, S.D., Ibrahim, T., Massberg, S., Schunkert, H., Laugwitz, K.-L., Kastrati, A., Sarafoff, N., Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE trial. J Am Coll Cardiol 65 (2015), 1619–1629.
14. Chang, K.-W., Arbit, B., Hsu, J.C., Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: a focused review. Int J Cardiol 243 (2017), 263–269.
15. Holmes, D.R., Kereiakes, D.J., Kleiman, N.S., Moliterno, D.J., Patti, G., Grines, C.L., Combining antiplatelet and anticoagulant therapies. J Am Coll Cardiol 54 (2009), 95–109.
16. Hurlen, M., Abdelnoor, M., Smith, P., Erikssen, J., Arnesen, H., Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347 (2002), 969–974.
17. Es, R.F., van Jonker, J.J.C., Verheugt, F.W.A., Deckers, J.W., Grobbee, D.E., Antithrombotics in the secondary preventionof events in coronary thrombosis-2 (ASPECT-2) Research Group. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet 360 (2002), 109–113.
18. Andrade, J.G., Deyell, M.W., Khoo, C., Lee, M., Humphries, K., Cairns, J.A., Risk of bleeding on triple antithrombotic therapy after percutaneous coronary intervention/stenting: a systematic review and meta-analysis. Can J Cardiol 29 (2013), 204–212.
19. Lamberts, M., Olesen, J.B., Ruwald, M.H., Hansen, C.M., Karasoy, D., Kristensen, S.L., Køber, L., Torp-Pedersen, C., Gislason, G.H., Hansen, M.L., Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Circulation 126 (2012), 1185–1193.
20. Lamberts, M., Gislason, G.H., Olesen, J.B., Kristensen, S.L., Schjerning Olsen, A.-M., Mikkelsen, A., Christensen, C.B., Lip, G.Y.H., Køber, L., Torp-Pedersen, C., Hansen, M.L., Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. J Am Coll Cardiol 62 (2013), 981–989.
21. Hess, C.N., Peterson, E.D., Peng, S.A., Lemos, J.A., de Fosbol, E.L., Thomas, L., Bhatt, D.L., Saucedo, J.F., Wang, T.Y., Use and outcomes of triple therapy among older patients with acute myocardial infarction and atrial fibrillation. J Am Coll Cardiol 66 (2015), 616–627.
22. D'Ascenzo, F., Taha, S., Moretti, C., Omedè P., Grossomarra, W., Persson, J., Lamberts, M., Dewilde, W., Rubboli, A., Fernández, S., Cerrato, E., Meynet, I., Ballocca, F., Barbero, U., Quadri, G., Giordana, F., Conrotto, F., Capodanno, D., DiNicolantonio, J., Bangalore, S., Reed, M., Meier, P., Zoccai, G., Gaita, F., Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention. Am J Cardiol 115 (2015), 1185–1193.
23. Ndrepepa, G., Guerra, E., Schulz, S., Fusaro, M., Cassese, S., Kastrati, A., Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention. J Thromb Thrombolysis 39 (2015), 35–42.
24. Halbritter, K., Beyer-Westendorf, J., Nowotny, J., Pannach, S., Kuhlisch, E., Schellong, S.M., Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome. J Thromb Haemost 11 (2013), 651–659.
25. Ruff, C.T., Giugliano, R.P., Braunwald, E., Hoffman, E.B., Deenadayalu, N., Ezekowitz, M.D., Camm, A.J., Weitz, J.I., Lewis, B.S., Parkhomenko, A., Yamashita, T., Antman, E.M., Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383 (2014), 955–962.
26. Patti, G., Rubboli, A., Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: suggested strategies tailored to an integrated evaluation of different risk profiles. Eur J Intern Med 41 (2017), e10–e11.